1. Action for Increasing Diversity, Market Access, and Capacity in Oncology Registration Trials—Is Africa the Answer? Report From a Satellite Session of the Accelerating Anti-Cancer Agent Development and Validation Workshop. (17th June 2022) Authors: Kizub, Darya; Manner, Cathyryne K.; Graef, Katy; Abubakar, Bello; Orem, Jackson; Odedina, Folakemi; Adeyeye, Mojisola Christianah; Nakigudde, Gertrude; Ayalew, Kassa; Kalidas, Chitkala; Lyerly, Herbert Kim; Norman, Thea; Fashoyin-Aje, Lola; Freedman, Jamie; Dent, Jennifer; Cance, Bill; Gralow, Julie Journal: JCO global oncology Issue: Volume 8(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patients. Issue 1 (January 2020) Authors: Zhou, Xinna; Qiao, Guoliang; Ren, Jun; Wang, Xiaoli; Wang, Shuo; Zhu, Siyu; Yuan, Yanhua; Morse, Michael A.; Hobeika, Amy; Lyerly, Herbert Kim Journal: Pain Issue: Volume 161:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Blood microbiota diversity determines response of advanced colorectal cancer to chemotherapy combined with adoptive T cell immunotherapy. (1st January 2021) Authors: Yang, Duo; Wang, Xiaoli; Zhou, Xinna; Zhao, Jing; Yang, Huabing; Wang, Shuo; Morse, Michael A.; Wu, Jiangping; Yuan, Yanhua; Li, Sha; Hobeika, Amy; Lyerly, Herbert Kim; Ren, Jun Journal: Oncoimmunology Issue: Volume 10:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies. (22nd May 2015) Authors: Song, Qing-Kun; Wang, Xiao-Li; Zhou, Xin-Na; Yang, Hua-Bing; Li, Yu-Chen; Wu, Jiang-Ping; Ren, Jun; Lyerly, Herbert Kim Journal: Oncologist Issue: Volume 20:Number 7(2015) Page Start: 773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Breast Cancer Challenges and Screening in China: Lessons From Current Registry Data and Population Screening Studies. (22nd May 2015) Authors: Song, Qing‐Kun; Wang, Xiao‐Li; Zhou, Xin‐Na; Yang, Hua‐Bing; Li, Yu‐Chen; Wu, Jiang‐Ping; Ren, Jun; Lyerly, Herbert Kim Journal: Oncologist Issue: Volume 20:Number 7(2015) Page Start: 773 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Combination of a novel heat shock protein 90-targeted photodynamic therapy with PD-1/PD-L1 blockade induces potent systemic antitumor efficacy and abscopal effect against breast cancers. Issue 9 (28th September 2022) Authors: Kaneko, Kensuke; Acharya, Chaitanya R; Nagata, Hiroshi; Yang, Xiao; Hartman, Zachary Conrad; Hobeika, Amy; Hughes, Philip F; Haystead, Timothy A J; Morse, Michael A; Lyerly, Herbert Kim; Osada, Takuya Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 9(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity. Issue 1 (17th January 2022) Authors: Abe, Shinya; Nagata, Hiroshi; Crosby, Erika J; Inoue, Yoshiyuki; Kaneko, Kensuke; Liu, Cong-Xiao; Yang, Xiao; Wang, Tao; Acharya, Chaitanya R; Agarwal, Pankaj; Snyder, Joshua; Gwin, William; Morse, Michael A; Zhong, Pei; Lyerly, Herbert Kim; Osada, Takuya Journal: Journal for immunotherapy of cancer Issue: Volume 10:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. DC-CIK as a widely applicable cancer immunotherapy. (2nd June 2020) Authors: Wang, Shuo; Wang, Xiaoli; Zhou, Xinna; Lyerly, Herbert Kim; Morse, Michael A.; Ren, Jun Journal: Expert opinion on biological therapy Issue: Volume 20:Number 6(2020) Page Start: 601 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. HER2-LAMP vaccines effectively traffic to endolysosomal compartments and generate enhanced polyfunctional T cell responses that induce complete tumor regression. Issue 1 (12th June 2020) Authors: Chen, Alan Chen; Xu, Renhuan; Wang, Tao; Wei, Junping; Yang, Xiao-Yi; Liu, Cong-Xiao; Lei, Gangjun; Lyerly, Herbert Kim; Heiland, Teri; Hartman, Zachary Conrad Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors. (29th November 2019) Authors: Qiao, Guoliang; Wang, Xiaoli; Zhou, Xinna; Morse, Michael A.; Wu, Jiangping; Wang, Shuo; Song, Yuguang; Jiang, Ni; Zhao, Yanjie; Zhou, Lei; Zhao, Jing; Di, Yan; Zhu, Lihong; Hobeika, Amy; Ren, Jun; Lyerly, Herbert Kim Journal: International journal of hyperthermia Issue: Volume 36(2020)Supplement 1 Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗